The Business Journals5d
Bill & Melinda Gates Foundation donates millions to pharma company
The business aims to develop more affordable treatments for RSV and malaria. Dyadic received a $3 million grant from the Gates Foundation. The grant funds monoclonal antibody development for RSV ...
Hosted on MSN7d
Dyadic International, Inc. (NASDAQ:DYAI) Q3 2024 Earnings Call Transcript
Dyadic International, Inc. (NASDAQ ... government agencies and nonprofits to support our engagement with interested partners.
Morningstar5d
Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology
JUPITER, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (NASDAQ: DYAI), a global biotechnology company, announced today that it has been awarded a $3 million grant from the ...
Seeking Alpha13d
Dyadic International, Inc. (DYAI) Q3 2024 Earnings Call Transcript
Dyadic expressly disclaims any duty to provide updates to ... government agencies and nonprofits to support our engagement with interested partners. To address the Mpox formerly monkeypox outbreak ...